SAT-214 Using machine learning models to predict baseline fibrosis stage in patients from phase 3 resmetirom trials (MAESTRO-NAFLD and MAESTRO-NASH)
Year: 2024
Type: conference-abstract
Source: Journal of Hepatology
Authors: Jörn M. Schattenberg, Quentin M. Anstee, Stephen A. Harrison, Mazen Noureddin, Rebecca Taub, Dominic Labriola, Jan Priel, Krishna Padmanabhan
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4399560106